Health · Pharma & Biotech · 3 hrs ago
FDA approves AstraZeneca drug for rare kidney disease in adults
AstraZeneca said the FDA approved a drug for a rare kidney disease in adults.
The FDA is the US agency that reviews medicines.
The announcement does not name the drug or the specific kidney disease.
The approval is for adult patients with that condition.
Rare diseases affect a relatively small number of people.
The announcement gives no details about the drug’s effects or what happens next.
The US Food and Drug Administration approved an AstraZeneca drug for a rare kidney disease in adults.
The drug and the kidney disease are not named in the available article text.
The article headline does not provide further details about the approval.
- Who
- The FDA approved a drug made by AstraZeneca.
- What
- The drug was approved for a rare kidney disease in adults.
- When
- Not stated
- Where
- Not stated
- Why
- The drug is for treating a rare kidney disease in adults.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Regulator
- FDA
- Company
- AstraZeneca
- Patient group
- Adults with a rare kidney disease